Memphasys Limited. Stock: price and insider trades · Australia
1 insider bought shares over the last 90 days, the latest by David Raymond Tasker, filed 21 Sept 2026.
Memphasys Limited.: what insiders have been doing
Every trade that managers of Memphasys Limited. disclose to ASX is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 5 insiders.
Only purchases show up on the open market, 1 purchase in all, filed by 1 insider. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 senior executive.
The last insider purchase was made public on 21 September 2026, 48 days ago.
With 5 filings in twelve months, the company is more active than the median of 4 filings across the 1,605 companies we follow on the same exchange. Our records for Memphasys Limited. go back to 2026, with 1 purchase and no sales on the open market in total.
Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
- ShareASXISIN AU000000MEM5ASX:2924-03144635-3A703362
- 1 shares@ €0.0031ShareASXISIN AU000000MEM5ASX:2924-03137613-3A702151Canonical exit: 20 Dec 2026 (T+90)
- ●Executives0ASX
- ShareASXASX:2924-03093439-3A693955
- ShareASXASX:2924-03093438-3A693954
5 of 5 declarations
About Memphasys Limited.
MEMPHASYS LIMITED is a company listed on the XASX, specializing in the development of innovative technologies for the biotechnology sector. It focuses on creating solutions to enhance medical diagnostics and treatments.